Immunohistochemistry and immunofluorescence analysis of tumor tissues revealed that CAR-M monotherapy increased the levels of activated caspase-3, as well as the infiltration of CD3+ T cells, CD8+ T cells, and GFP-labeled CAR-Ms relative to controls. The gene discussed is CASP3; the disease is neoplasm.